Side Effects Comparison# Retatrutide Side Effects# Phase 2 data (n=338 obesity trial): Nausea : ~25% at higher doses (8-12 mg) Diarrhea : ~20% Vomiting : ~15% Constipation : Common Decreased appetite : Common (pharmacological effect) Heart rate : Small increase (2-4 bpm), potentially related to glucagon component Injection site reactions : Mild, transient Discontinuation rate : 6-10% due to adverse events The glucagon receptor component introduces theoretical concerns for hyperglycemia (counterbalanced by GLP-1/GIP in practice), cardiovascular effects (chronotropic glucagon action), and hepatic effects, none of which produced safety signals in Phase 2 but require larger-scale monitoring
However, most people with mild reflux or indigestion tolerate the medication well once initial adaptation passes
Opening and Labeling: When opening a new vial, write the date on the vial
The neuroprotective effects of incretin receptor agonists are therefore due in part by reducing the chronic inflammation response and helping to normalize insulin sensitization and other growth factor signaling pathways
Later, you may need to have a procedure called a colonoscopy, which is an internal examination of the colon